U.S. Department of Justice

Medication Assisted Treatment (MAT) in Corrections

Would you like to know more?

Our free Information Center Help Desk can help you locate additional information on this topic and can also attempt to find additional training, funding, publications and contacts that may be helpful.

Help Desk

Related Library Topics

Created: Apr. 20, 2016. Last reviewed: 1 month(s) ago.

A New Normal: Addressing Opioid Use Through the Criminal Justice System

Pope, Leah, et al., 2017

This report describes how some innovative jurisdictions are implementing harm reduction strategies in order to reduce overdose deaths, improve the wellbeing of justice system-involved people, and advance the health and safety of their communities.

NIMH: Prison & Jail Medication Assisted Treatment (MAT) Training Video

The National Institute of Mental Health (NIMH) brought attention to a video highlighting medication-assisted treatment for people in the U.S. prison system coping with drug addiction.

Medication Assisted Treatment (MAT) Course [Online Training]

The National Drug Court Institute (NDCI) with funding from the Office of National Drug Control Policy, Executive Office of the White House in collaboration with American Academy of Addiction Psychiatry (AAAP) developed an online training curriculum designed to educate drug court professionals on medication assisted treatments (MAT) for substance use disorders with a major focus on opioid use disorders. Nine modules were developed and are available at this website.

Narcan: What Happens Next? Using Narcan as a Starting Point for Local and County Corrections Policies

Mazza, Frank, 2017

The Hudson County Department of Corrections (HCDOC) has partnered with Alkermes, the manufacturer of the drug Vivitrol, to bring medication-assisted treatment to the jail.

Pharmacotherapy for Opioid Dependence in Jails and Prisons: Research Review Update and Future Directions

Sharma, Anjalee, et al., 2016

Medication Assisted Treatment (MAT)

Pennsylvania Department of Corrections, 2016

Extended-Release Naltrexone Lowers Relapse Rates in Ex-Offenders

Lee, Joshua D., et. al., 2016

In this trial involving criminal justice offenders, extended-release naltrexone was associated with a rate of opioid relapse that was lower than that with usual treatment.

Mounting an Evidence-Based Criminal Justice Response to Substance Abuse and Drug Offending in Massachusetts

Forman, Benjamin, Jonathan Jones, and Abigail Hiller, 2016

This paper is one in a series of policy briefs examining Justice Reinvestment in Massachusetts.

Methdaone Continuaton Versus Forced Withdrawl on Incarceration in a Combined US Prison and Jail: A Randomised , Open-Label Trial

Rich, Josiah D., et al., 2015

Methadone is an effective treatment for opioid dependence. When people who are receiving methadone maintenance treatment for opioid dependence are incarcerated in prison or jail, most US correctional facilities discontinue their methadone treatment, either gradually, or more often, abruptly. This discontinuation can cause uncomfortable symptoms of withdrawal and renders prisoners susceptible to relapse and overdose on release. We aimed to study the effect of forced withdrawal from methadone upon incarceration on individuals' risk behaviours and engagement with post-release treatment programmes.

Overdose Prevention for Prisoners in New York: A Novel Program and Collaboration

Zucker, Howard, et al., 2015

This is a brief report on the establishment of a new program in New York State prisons to prepare prisoners to avoid the increased risks of drug overdose death associated with the transition to the community by training them in overdose prevention and making available naloxone, a medication that quickly reverses the effects of an opioid overdose, to all prisoners as they re-enter the community.

Opioid Addiction & Corrections [PPT]

Maurer, Kathleen F., Connecticut Department of Correction, 2015.

Introduction of methadone program to Connecticut’s criminal justice population.